Literature DB >> 31970461

[Prevention of cardiovascular diseases in childhood and adolescence].

Daniel Goeder1, Renate Oberhoffer2.   

Abstract

Cardiovascular diseases are among the leading causes of death worldwide. Apart from a few exceptions heart attack, stroke and peripheral arterial occlusive disease first occur in later adulthood. The cornerstone for these diseases, however, is already laid by accelerated vascular aging in childhood. Apart from pediatric medical preventive check-ups, the medical care of the parents should also be a reason for taking action. A detailed family history enables many conclusions to be drawn about the cardiovascular risk of the next generation This requires targeted diagnostics and appropriate interventions in childhood ranging from lifestyle measures up to pharmaceutical therapy. In this context the current guidelines on the diagnostics and treatment of hypercholesterolemia and arterial hypertension in children and adolescents are also presented.

Entities:  

Keywords:  Cardiovascular risk; Child; Exercise; Lifestyle; Vascular aging

Mesh:

Year:  2020        PMID: 31970461     DOI: 10.1007/s00059-019-04887-x

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  12 in total

1.  The fetal and infant origins of adult disease.

Authors:  D J Barker
Journal:  BMJ       Date:  1990-11-17

2.  Prevalence of and risk factors for childhood overweight and obesity.

Authors:  Paul J Veugelers; Angela L Fitzgerald
Journal:  CMAJ       Date:  2005-09-13       Impact factor: 8.262

3.  [National Recommendations for Physical Activity and Physical Activity Promotion].

Authors:  Klaus Pfeifer; Alfred Rütten
Journal:  Gesundheitswesen       Date:  2017-04-11

4.  Short-term efficacy and safety of pravastatin in 72 children with familial hypercholesterolemia.

Authors:  H C Knipscheer; C C Boelen; J J Kastelein; D E van Diermen; B E Groenemeijer; A van den Ende; H R Büller; H D Bakker
Journal:  Pediatr Res       Date:  1996-05       Impact factor: 3.756

5.  Familial hypercholesterolemia in primary care in Germany. Diabetes and cardiovascular risk evaluation: Targets and Essential Data for Commitment of Treatment (DETECT) study.

Authors:  Nina Schmidt; Burkhard Schmidt; Alexander Dressel; Ingrid Gergei; Jens Klotsche; Lars Pieper; Hubert Scharnagl; Marcus E Kleber; Winfried März; Hendrik Lehnert; David Pittrow; Günter Stalla; Hans-Ulrich Wittchen; Tanja B Grammer
Journal:  Atherosclerosis       Date:  2017-08-19       Impact factor: 5.162

6.  Early life risk factors for obesity in childhood: cohort study.

Authors:  John J Reilly; Julie Armstrong; Ahmad R Dorosty; Pauline M Emmett; A Ness; I Rogers; Colin Steer; Andrea Sherriff
Journal:  BMJ       Date:  2005-05-20

7.  "Vascular age" is advanced in children with atherosclerosis-promoting risk factors.

Authors:  Joseph Le; Danna Zhang; Spencer Menees; Jie Chen; Geetha Raghuveer
Journal:  Circ Cardiovasc Imaging       Date:  2009-11-17       Impact factor: 7.792

8.  Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized controlled trial.

Authors:  Albert Wiegman; Barbara A Hutten; Eric de Groot; Jessica Rodenburg; Henk D Bakker; Harry R Büller; Eric J G Sijbrands; John J P Kastelein
Journal:  JAMA       Date:  2004-07-21       Impact factor: 56.272

9.  Familial hypercholesterolaemia: a pressing issue for European health care.

Authors:  Philippa Brice; Hilary Burton; Christopher W Edwards; Steve E Humphries; Timothy J Aitman
Journal:  Atherosclerosis       Date:  2013-10-02       Impact factor: 5.162

Review 10.  Recommendations for promoting physical activity for children and adolescents in Germany. A consensus statement.

Authors:  Christine Graf; Ralph Beneke; Wilhelm Bloch; Jens Bucksch; Sigrid Dordel; Stefanie Eiser; Nina Ferrari; Benjamin Koch; Susanne Krug; Wolfgang Lawrenz; Kristin Manz; Roland Naul; Renate Oberhoffer; Eike Quilling; Henry Schulz; Theo Stemper; Günter Stibbe; Walter Tokarski; Klaus Völker; Alexander Woll
Journal:  Obes Facts       Date:  2014-05-10       Impact factor: 3.942

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.